Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, is to acquire the IndivuServ business unit of Hamburg-based Indivumed. A Share Purchase Agreement (SPA) between both parties was executed on December 29, 2022, and is expected to close in April 2023. Indivumed has a global reputation for the provision and…

You must be a HMI Subscriber to view this content.

Subscribe Now »

RELATED ARTICLESMORE FROM AUTHOR